BR132016015841E2 - recombinant antigens from porcine circovirus 2 (pcv-2) for vaccine formulations and use - Google Patents
recombinant antigens from porcine circovirus 2 (pcv-2) for vaccine formulations and use Download PDFInfo
- Publication number
- BR132016015841E2 BR132016015841E2 BR132016015841A BR132016015841A BR132016015841E2 BR 132016015841 E2 BR132016015841 E2 BR 132016015841E2 BR 132016015841 A BR132016015841 A BR 132016015841A BR 132016015841 A BR132016015841 A BR 132016015841A BR 132016015841 E2 BR132016015841 E2 BR 132016015841E2
- Authority
- BR
- Brazil
- Prior art keywords
- pcv
- vaccine formulations
- porcine circovirus
- recombinant antigens
- antigens
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
antígenos recombinantes do porcine circovirus 2 (pcv-2) para formulações vacinais e uso. o presente certificado de adição se refere à obtenção do antígeno recombinante do capsídeo viral do porcine circovirus 2 (pcv-2) e suas modificações, mediante expressão em sistema procariótico, recuperação de partículas semelhantes a vírus (vlps) e sua utilização em formulações vacinais. os antígenos e as formulações vacinais podem ser empregados na imunização de animais em programas de controle das doenças associadas ao pcv-2 nos sistemas de produção de suínos convencionais e representam alternativas às vacinas disponíveis no mercado.recombinant antigens from porcine circovirus 2 (pcv-2) for vaccine formulations and use. this certificate of addition refers to obtaining the recombinant antigen from the viral capsid of the porcine circovirus 2 (pcv-2) and its modifications, through expression in a prokaryotic system, recovery of virus-like particles (vlps) and its use in vaccine formulations. antigens and vaccine formulations can be used to immunize animals in disease control programs associated with pcv-2 in conventional swine production systems and represent alternatives to vaccines available on the market.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR132016015841A BR132016015841E2 (en) | 2016-07-07 | 2016-07-07 | recombinant antigens from porcine circovirus 2 (pcv-2) for vaccine formulations and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR132016015841A BR132016015841E2 (en) | 2016-07-07 | 2016-07-07 | recombinant antigens from porcine circovirus 2 (pcv-2) for vaccine formulations and use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR132016015841E2 true BR132016015841E2 (en) | 2020-04-07 |
Family
ID=70157959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR132016015841A BR132016015841E2 (en) | 2016-07-07 | 2016-07-07 | recombinant antigens from porcine circovirus 2 (pcv-2) for vaccine formulations and use |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR132016015841E2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112898435A (en) * | 2021-01-14 | 2021-06-04 | 山西农业大学 | Soluble fusion protein DT390-Cap as well as preparation method and application thereof |
-
2016
- 2016-07-07 BR BR132016015841A patent/BR132016015841E2/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112898435A (en) * | 2021-01-14 | 2021-06-04 | 山西农业大学 | Soluble fusion protein DT390-Cap as well as preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR102013001893A8 (en) | porcine circovirus 2 (pcv-2) recombinant antigens for vaccine formulations, diagnostic kit and use | |
Robinson et al. | Global Foot‐and‐Mouth Disease Research Update and Gap Analysis: 3‐Vaccines | |
EA202091513A1 (en) | VACCINES AGAINST HEPATITIS B VIRUS (HBV) AND THEIR APPLICATION | |
BR112016019525A2 (en) | uspa2 protein constructs and their use | |
EA201990718A1 (en) | VECTORS OF Adenovirus of dogs | |
CY1118573T1 (en) | USE OF A MODIFIED EYEVOLOGY VIRUS FOR EXTREMELY DEFECTS ANTI-VOLUME OR OTHER INVESTIGATIVE FACTORS | |
Lee et al. | Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use | |
WO2014150822A3 (en) | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use | |
Kortekaas et al. | Rift Valley fever vaccine development, progress and constraints | |
Lambe | Novel viral vectored vaccines for the prevention of influenza | |
BR112016028418A2 (en) | adjuvant composition, vaccine, cd40 agonist antibody or a part thereof, pharmaceutical composition, construct, cell, and epitope mapping method of a polypeptide | |
HRP20230752T1 (en) | Foot-and-mouth disease vaccine | |
AR108014A1 (en) | UNIVERSAL VACCINE FOR VIRAL DISEASES AND VACCINATION METHOD | |
BR112017027895A2 (en) | recombinant viral vectors containing minor prrsv proteins and methods of manufacturing and using these | |
BR132016015841E2 (en) | recombinant antigens from porcine circovirus 2 (pcv-2) for vaccine formulations and use | |
WO2018066999A3 (en) | Chimeric enterovirus virus-like particles | |
van de Sandt et al. | Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine | |
Hernandez et al. | Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs | |
Kondakova et al. | Rotavirus vaccines: new strategies and approaches | |
Tabynov et al. | Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza | |
AR101256A1 (en) | VACCINE COMPOSITION THAT INCLUDES IPV AND CYCLODEXTRINES | |
JP2019506168A5 (en) | ||
MX2022007217A (en) | Epitopic vaccine for african swine fever virus. | |
HUA et al. | Advance in human papillomavirus major capsid protein L1-based vaccines | |
BR112023018838A2 (en) | VACCINE COMPOSITIONS AND METHODS FOR USE THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of an application: publication of a patent application or of a certificate of addition of invention | ||
B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07K 14/01 , A61K 39/012 , A61K 31/20 , C12N 15/34 , C12R 1/93 , G01N 33/569 Ipc: C07K 14/01 (2006.01), A61K 39/12 (2006.01), A61P 3 |